Cleave Therapeutics Stock
Cleave Therapeutics develops small-molecule drugs that target the VCP/p97 enzyme, aiming to disrupt cellular stress and protein homeostasis pathways that cancer and neurodegeneration rely on. Its clinical asset CB-5339 is an oral inhibitor being developed for hematologic malignancies and solid tumors
Sign up for SecondMarket® to view the market and buy or sell Cleave Therapeutics Stock
Buy + SellSee Cleave Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Cleave Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Cleave Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get StartedCleave Therapeutics Major Investors
-
Osage University Partners
-
Arcus Ventures
-
Clarus Ventures LLC
-
5AM Ventures
-
New Enterprise Associates Inc (NEA)
-
Astellas Venture Management
-
Osage Partners
-
Celgene Corp
-
Nextech Invest
-
Celgene Corporation
-
U.S. Venture Partners
-
OrbiMed Advisors
Learn More About Cleave Therapeutics Stock
Buy Cleave Therapeutics Stock
01Cleave Therapeutics stock does not trade on public stock exchanges. Cleave Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cleave Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Cleave Therapeutics Stock
02Cleave Therapeutics Stock does not trade on public stock exchanges. In order to sell Cleave Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cleave Therapeutics Stock Price
03Cleave Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Cleave Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Cleave Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Cleave Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Cleave Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cleave Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Cleave Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cleave Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Cleave Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cleave Therapeutics IPO
08Cleave Therapeutics is a private company and has not had an IPO. There is currently no Cleave Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Cleave Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Cleave Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.